Goldman Sachs analyst Robert Cox lowered the firm’s price target on Arthur J. Gallagher (AJG) to $315 from $361 and keeps a Buy rating on the shares. Adjusted EPS of $2.32 missed consensus due to lower-than-expected Brokerage EBITDAC, primarily from timing issues related to AssuredPartners contributions, the analyst tells investors in a research note. Brokerage organic growth also came in slightly below expectations amid timing shifts in large life sales and international contingents, while renewal pricing softened modestly. Despite these short-term headwinds, management maintained 2026 organic growth guidance of 6%+ and noted improving Q4 trends, though results may prompt a mildly negative initial market reaction, the firm says.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AJG:
- Arthur J. Gallagher price target lowered to $275 from $315 at Keefe Bruyette
- Arthur J. Gallagher price target lowered to $295 from $340 at Piper Sandler
- Arthur J. Gallagher Reports Strong Q3 2025 Growth
- Arthur J. Gallagher Reports Q3 2025 Revenue Growth
- Arthur J. Gallagher reports Q3 EPS $2.32, consensus $2.54
